...
首页> 外文期刊>Journal of clinical laboratory analysis. >Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy
【24h】

Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy

机译:碎裂的红细胞可能是造血干细胞移植相关血栓性微血管病的可能的预后标志

获取原文

摘要

Background Fragmented red cell (FRC) by automated hematologic analyzer is known to detect schistocyte. In this study, it is noted that FRC might be a favorable prognostic marker of hematopoietic stem cell transplantation associated thrombotic microangiopathy (TA-TMA). Methods The peripheral blood samples and clinical data of 89 patients were collected. The diagnosis of TA-TMA was defined by the Blood and Marrow Transplant Clinical Trials Network's criteria and schistocyte or both schistocyte- and FRC-positive cases and other parameters fulfilled are regarded as TA-TMA. Results Schistocyte and FRC displayed a correlation coefficient of 0.461 ( P Conclusion As evidenced by the data, FRC might be a favorable prognostic marker for TA-TMA, but additional studies with larger patients groups are required for validation of clinical applications.
机译:背景技术已知通过自动血液分析仪破碎的红细胞(FRC)可检测血细胞。在这项研究中,注意到FRC可能是造血干细胞移植相关的血栓性微血管病(TA-TMA)的有利预后标志物。方法收集89例患者的外周血标本和临床资料。 TA-TMA的诊断由血液和骨髓移植临床试验网络的标准定义,血吸虫细胞或血吸虫和FRC阳性病例均满足,并将其他满足的参数视为TA-TMA。结果血细胞和FRC的相关系数为0.461(P结论正如数据所证明的,FRC可能是TA-TMA的有利预后标志物,但需要对更大患者组进行更多研究才能验证临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号